Timothy Hatlen to Granulocyte-Macrophage Colony-Stimulating Factor
This is a "connection" page, showing publications Timothy Hatlen has written about Granulocyte-Macrophage Colony-Stimulating Factor.
Connection Strength
0.049
-
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR). Eur Respir J. 2023 02; 61(2).
Score: 0.049
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.